Cargando…
A systemic administration of liposomal curcumin inhibits radiation pneumonitis and sensitizes lung carcinoma to radiation
Radiation pneumonitis (RP) is an important dose-limiting toxicity during thoracic radiotherapy. Previous investigations have shown that curcumin is used for the treatment of inflammatory conditions and cancer, suggesting that curcumin may prevent RP and sensitize cancer cells to irradiation. However...
Autores principales: | Shi, Hua-shan, Gao, Xiang, Li, Dan, Zhang, Qiong-wen, Wang, Yong-sheng, Zheng, Yu, Cai, Lu-Lu, Zhong, Ren-ming, Rui, Ao, Li, Zhi-yong, Zheng, Hao, Chen, Xian-cheng, Chen, Li-juan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3368513/ https://www.ncbi.nlm.nih.gov/pubmed/22679371 http://dx.doi.org/10.2147/IJN.S31439 |
Ejemplares similares
-
Inhaled curcumin mesoporous polydopamine nanoparticles against radiation pneumonitis
por: Chen, Ting, et al.
Publicado: (2022) -
Curcumin Mitigates Radiation-induced Lung Pneumonitis and Fibrosis in Rats
por: Amini, Paiman, et al.
Publicado: (2018) -
Protective efficacy of inhaled quercetin for radiation pneumonitis
por: Qin, Meng, et al.
Publicado: (2017) -
Effects of diabetes on the development of radiation pneumonitis
por: Dong, Guangtong, et al.
Publicado: (2021) -
Genetic variants of SP‐D confer susceptibility to radiation pneumonitis in lung cancer patients undergoing thoracic radiation therapy
por: Xu, Li, et al.
Publicado: (2019)